US biotech giant Moderna Therapeutics – which is backed by Singapore-based EDBI and Sequoia Capital China – has filed with the SEC to raise up to $500 million in an initial public offering, according to IPO investment manager Renaissance Capital.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com